SUWANEE, Ga., Sept. 15, 2017 -- Digirad Corporation (NASDAQ:DRAD), today announced that it will present at the Sidoti & Company Fall 2017 Conference on Thursday, September 28, 2017, at the New York Marriott Marquis hotel in Times Square, New York City.
During the presentation, taking place at 3:05 PM (EDT), Matt Molchan, President and CEO, will provide an overview of the Company’s business. Mr. Molchan and Mr. Jeff Keyes, Digirad’s CFO, will also be available to meet with investors on-site at the conference that day.
The presentation and live webcast will be available from the Events & Presentations link on the Investor Relations page of the Digirad website at www.digirad.com.
About Digirad
Digirad delivers convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis. Digirad’s diverse portfolio of mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring, provides hospitals, physician practices, and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment. For more information, please visit www.digirad.com.
About Sidoti & Company
Sidoti & Company, LLC is Wall Street’s preeminent provider of equity research generally focused on companies with market capitalizations of under $3 billion. They cover over 250 companies across a range of industries. The companies covered by their traditional research typically have a history of profitability, maintain strong balance sheets, and tend to have limited, if any, coverage by other Wall Street firms.
For those interested in attending, please contact Caitlin Adams at [email protected] or visit https://www.meetmax.com/sched/event_43487/~public/conference_register.html?event_id=43487&bank_access=0 for more information.
For more information contact:
Jeffry Keyes
Chief Financial Officer
858-726-1600
[email protected]


Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



